Categories Earnings, Technology

BlackBerry beats Q2 earnings expectations; revenues miss estimates

BlackBerry Limited (NYSE: BB) reported better-than-expected earnings for the second quarter of 2020 but revenues fell short of estimates. The stock tumbled over 11% in premarket hours on Tuesday.

Total revenue of $244 million was up 16% from the same period last year but below forecasts of $265 million. On an adjusted basis, revenue grew 22% to $261 million.

BlackBerry beats earnings estimates for Q2 2020 but revenues fall short of expectations

On a GAAP basis, the company reported a net loss of $44 million compared to a net income of $43 million last year. GAAP loss per share was $0.10 compared to a loss of $0.04 per share in the year-ago quarter. Adjusted EPS was $0.00, better than the estimated loss of $0.01 per share.  

On a GAAP basis, Software and Services revenues grew 24% year-over-year to $239 million. Adjusted Software and Services revenues rose 30% to $256 million.

Also read: BlackBerry Q2 2020 Earnings Preview

During the quarter, IoT revenues fell 3% to $133 million versus the year-ago period. Revenues from BlackBerry Cylance totaled $35 million and Licensing revenues grew 27% to $71 million. On a geographic basis, revenues in North America grew 34% to $179 million while in EMEA and other regions, the company posted double-digit revenue declines.

For the full year of 2020, the company expects adjusted revenue growth to be 23-25%, driven by a double-digit percentage increase in billings year-over-year.

BlackBerry promoted Steve Rai from deputy CFO to CFO and named Steve Capelli as the new Chief Revenue Officer. Mr. Capelli will be in charge of business development activities. Both changes will take effect on October 1, 2019.

Listen to on-demand earnings calls and hear how management responds to analysts’ questions

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

What to expect when J.M. Smucker (SJM) reports Q2 2025 earnings results

Shares of The J.M. Smucker Co. (NYSE: SJM) stayed red on Friday. The stock has dropped 6% over the past three months. The branded foods company is slated to report

Earnings Summary: Highlights of BJ’s Wholesale Club’s Q3 2024 results

Department store chain BJ’s Wholesale Club Holdings, Inc. (NYSE: BJ) has reported financial results for the third quarter of 2024, reporting a 3% increase in net sales. Adjusted earnings, on a

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top